TrialCancer2017

Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.

Thomas B Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.